on 27 Apr 2004
Last Applicant/ Owned by
StageZero Life Sciences Ltd.
70 East Beaver Creek Rd. Unit #30
Richmond Hill,, , L4B 3B2
Serial Number
UK00903782687 filed on 27th Apr 2004
Registration Number
UK00903782687 registered on
04th Oct 2005
Correspondent Address
Aurora Building, Counterslip
Bristol,
BS1 6BX
Diagnostic assays and test kits for use in clinical, laboratory, medical, and chemical research and development and used to diagnose, prognose, predict or treat diseases; prognostic test kits for identifying disease risk factors and responses to therapeutic treatment; diagnostic preparations, including preparations of extracts, assays, nucleic acids including cDNA clones and polymerase chain reaction (PCR) and real time PCR primers, proteins and antibodies, and molecular arrays of biological material for clinical or medical laboratory use; prescription pharmaceutical preparations for use in diagnosing and treating human diseases and conditions, including circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, renal, metabolic or central nervous system diseases and weight disorders.
Optical disc media and other electronic media providing genomic, proteomic and gene expression profile information for use in selecting therapeutics, evaluating efficacy and toxicity of treatments, evaluating treatment progression, prognosing disease or disease progression, and identifying disease heredity risk factors.
Research and development, validation, testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology, genomics, proteomics, diagnostics, pharmacogenomics, toxicogenomics and personalized medicine; diagnostic services including diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, identifying physiological characteristics, and evaluating efficacy of treatment; medical and diagnostic services, including diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, and drug monitoring and monitoring of patient health progression; providing genomic, proteomic, and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors; computer services, including computer tracking of and providing access to databases of life sciences information via global, national and local computer networks in the field of pharmacogenomics, diagnostics, personalized medicine and toxicogenomics.
UK00903782687
Word
Individual